NURECA · Health Care · 2026-08-21

Nureca Ltd

6.4★ FairStrong +6.9Stage 2 · wk 1In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹306.7
-4.01% today
₹307 Cr · Micro cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, yoga and exercise products, fitness tracking products, and dental and personal care products. It also provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, fitness trackers, and smart weighing scales. In addition, the company provides orthopedic cushions, heating pads, and breast pumps. The company offers its products under the Dr Trust, Dr Physio, and Trumom brands. It markets its products through e-commerce platforms, distributors, retailers, and its websites. Nureca Limited was incorporated in 2016 and is based in Chandigarh, India.

Visit company website →
P/E (TTM)
24.7
Forward —
vs 52W High
-11.4%
₹206.8 lo₹346.3 hi
11.4% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 1
1w13w26w
Week 1 — fresh breakout, verify structure
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
11.3%
200 DMA: ₹275.4 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.16x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +7.8% vs MA50 +11.9%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #29 of 84 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
56.1%
20d Δ
+5.6pp
1M return
+2.7%
3M return
+10.4%
Industry Stage-2 % · last 20 days
Ranks #24 of 58 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 16w
S4 23w
S2 16w
S4 16w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 1w → S1 10w → S4 7w → S1 5w → S2 16w → S3 3w → S4 23w → S1 7w → S2 5w → S3 3w → S4 5w → S2 6w → S3 3w → S4 11w → S1 10w → S4 10w → S1 3w → S2 16w → S3 5w → S4 16w → S1 2w → S2 1w current
Total tracked: 167 weeks across 22 stage runs.
1M
+3.3%
3M
+12.7%
6M
+8.6%
YTD
+8.1%
1Y
+29.9%
Scan Membership
Breakout Watch
Latest: 2026-08-17
4 appearances in last 60 days. First seen: 2024-10-14.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 1 · Vol —x
2026-08-20S2
Wk 1 · Vol —x
2026-08-19S2
Wk 1 · Vol —x
2026-08-18S2
Wk 1 · Vol —x
2026-08-17S21→2
Wk 1 · Vol —x
2026-08-14S1
Wk 3 · Vol —x
2026-08-13S1
Wk 2 · Vol —x
2026-08-12S1
Wk 2 · Vol —x
2026-08-11S1
Wk 2 · Vol —x
2026-08-10S1
Wk 2 · Vol —x
2026-08-07S1
Wk 2 · Vol —x
2026-08-06S1
Wk 1 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹282.6
200 DMA
₹275.4
52W High
₹346.3
52W Low
₹206.8
5D Low
₹306.7
Resistance levels (recent highs)
20d High
₹346.3
60d High
₹346.3
120d High
₹346.3
250d High
₹346.3
Next resistance
+12.9%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.